BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18236385)

  • 1. Kinetic studies on aminopeptidase M-mediated degradation of human hemorphin LVV-H7 and its N-terminally truncated products.
    John H; John S; Forssmann WG
    J Pept Sci; 2008 Jul; 14(7):797-803. PubMed ID: 18236385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase.
    Lee J; Mustafa T; McDowall SG; Mendelsohn FA; Brennan M; Lew RA; Albiston AL; Chai SY
    J Pharmacol Exp Ther; 2003 Apr; 305(1):205-11. PubMed ID: 12649370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro degradation of the human hemorphin LVV-H7 in mammalian plasma analysed by capillary zone electrophoresis and mass spectrometry.
    John H; Schulz S; Forssmann WG
    Biopharm Drug Dispos; 2007 Mar; 28(2):73-85. PubMed ID: 17173283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validated multi-component CZE-UV procedure for the quantification of human hemorphin LVV-H7 in plasma stability studies.
    John H; Schulz S; Forssmann WG
    Anal Bioanal Chem; 2006 Sep; 386(2):235-43. PubMed ID: 16838155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin D is a good candidate for the specific release of a stable hemorphin from hemoglobin in vivo: VV-hemorphin-7.
    Fruitier I; Garreau I; Piot JM
    Biochem Biophys Res Commun; 1998 May; 246(3):719-24. PubMed ID: 9618278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LVV-hemorphin 7 and angiotensin IV in correlation with antinociception and anti-thermal hyperalgesia in rats.
    Cheng BC; Tao PL; Cheng YY; Huang EY
    Peptides; 2012 Jul; 36(1):9-16. PubMed ID: 22484286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms.
    Albiston AL; Pederson ES; Burns P; Purcell B; Wright JW; Harding JW; Mendelsohn FA; Weisinger RS; Chai SY
    Behav Brain Res; 2004 Sep; 154(1):239-43. PubMed ID: 15302130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo processing of LVV-hemorphin-7 in rat brain and blood utilizing microdialysis combined with electrospray mass spectrometry.
    Nydahl KS; Pierson J; Nyberg F; Caprioli RM; Andrén PE
    Rapid Commun Mass Spectrom; 2003; 17(8):838-44. PubMed ID: 12672139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-regulated aminopeptidase: analysis of peptide substrate and inhibitor binding to the catalytic domain.
    Ye S; Chai SY; Lew RA; Albiston AL
    Biol Chem; 2007 Apr; 388(4):399-403. PubMed ID: 17391061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid peptides derived from hemoglobin: hemorphins.
    Zhao Q; Garreau I; Sannier F; Piot JM
    Biopolymers; 1997; 43(2):75-98. PubMed ID: 9216245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LVV- and VV-hemorphins: comparative levels in rat tissues.
    Yatskin ON; Philippova MM; Blishchenko EYu ; Karelin AA; Ivanov VT
    FEBS Lett; 1998 May; 428(3):286-90. PubMed ID: 9654150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemorphins: substrates and/or inhibitors of dipeptidyl peptidase IV. Hemorphins N-terminus sequence influence on the interaction between hemorphins and DPPIV.
    Cohen M; Fruitier-Arnaudin I; Piot JM
    Biochimie; 2004 Jan; 86(1):31-7. PubMed ID: 14987798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain processing of hemorphin-7 peptides in various subcellular fractions from rats.
    Murillo L; Piot JM; Coitoux C; Fruitier-Arnaudin I
    Peptides; 2006 Dec; 27(12):3331-40. PubMed ID: 17097762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular insights into the interaction of hemorphin and its targets.
    Ali A; Baby B; Soman SS; Vijayan R
    Sci Rep; 2019 Oct; 9(1):14747. PubMed ID: 31611567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic of in vitro generation of some hemorphins: early release of LVV-hemorphin-7, precursor of VV-hemorphin-7.
    Dagouassat N; Garreau I; Zhao Q; Sannier F; Piot JM
    Neuropeptides; 1996 Feb; 30(1):1-5. PubMed ID: 8868292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hemoglobin derived peptide LVV-hemorphin-7 evokes behavioral effects mediated by oxytocin receptors.
    da Cruz KR; Turones LC; Camargo-Silva G; Gomes KP; Mendonça MM; Galdino P; Rodrigues-Silva C; Santos RAS; Costa EA; Ghedini PC; Ianzer D; Xavier CH
    Neuropeptides; 2017 Dec; 66():59-68. PubMed ID: 28985964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of modulating residues defining the catalytic cleft of insulin-regulated aminopeptidase.
    Ye S; Chai SY; Lew RA; Ascher DB; Morton CJ; Parker MW; Albiston AL
    Biochem Cell Biol; 2008 Jun; 86(3):251-61. PubMed ID: 18523486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The insulin-regulated aminopeptidase IRAP is colocalised with GLUT4 in the mouse hippocampus--potential role in modulation of glucose uptake in neurones?
    Fernando RN; Albiston AL; Chai SY
    Eur J Neurosci; 2008 Aug; 28(3):588-98. PubMed ID: 18702730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of appearance of four hemorphins from bovine hemoglobin peptic hydrolysates by HPLC coupled with photodiode array detection.
    Zhao Q; Sannier F; Piot JM
    Biochim Biophys Acta; 1996 Jun; 1295(1):73-80. PubMed ID: 8679676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family of hemorphins: co-relations between amino acid sequences and effects in cell cultures.
    Blishchenko EY; Sazonova OV; Kalinina OA; Yatskin ON; Philippova MM; Surovoy AY; Karelin AA; Ivanov VT
    Peptides; 2002 May; 23(5):903-10. PubMed ID: 12084521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.